ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,576,925 | -47.0% | 409,700 | +1.5% | 0.00% | 0.0% |
Q2 2023 | $8,641,391 | -45.9% | 403,803 | +2.2% | 0.00% | -50.0% |
Q1 2023 | $15,976,887 | +90533.6% | 395,076 | +4.3% | 0.00% | 0.0% |
Q4 2022 | $17,628 | -99.9% | 378,941 | +4.4% | 0.00% | -33.3% |
Q3 2022 | $18,827,000 | +15.0% | 362,981 | +4.8% | 0.00% | +50.0% |
Q2 2022 | $16,368,000 | -34.8% | 346,272 | -1.8% | 0.00% | -33.3% |
Q1 2022 | $25,106,000 | -0.1% | 352,716 | +5.0% | 0.00% | 0.0% |
Q4 2021 | $25,126,000 | +32.5% | 336,008 | +0.7% | 0.00% | 0.0% |
Q3 2021 | $18,962,000 | +30.4% | 333,793 | +1.0% | 0.00% | +50.0% |
Q2 2021 | $14,541,000 | -5.7% | 330,409 | +5.7% | 0.00% | 0.0% |
Q1 2021 | $15,414,000 | +28.2% | 312,544 | +9.4% | 0.00% | 0.0% |
Q4 2020 | $12,022,000 | -4.5% | 285,580 | +3.9% | 0.00% | 0.0% |
Q3 2020 | $12,588,000 | -6.0% | 274,986 | +3.1% | 0.00% | -33.3% |
Q2 2020 | $13,391,000 | +0.6% | 266,717 | +3.1% | 0.00% | 0.0% |
Q1 2020 | $13,308,000 | -53.5% | 258,775 | -44.1% | 0.00% | 0.0% |
Q4 2019 | $28,610,000 | +105.2% | 463,110 | +99.5% | 0.00% | 0.0% |
Q3 2019 | $13,945,000 | -24.6% | 232,112 | +5.8% | 0.00% | -25.0% |
Q2 2019 | $18,504,000 | -8.8% | 219,301 | +3.2% | 0.00% | -20.0% |
Q1 2019 | $20,292,000 | -27.9% | 212,443 | -46.5% | 0.01% | +25.0% |
Q4 2018 | $28,146,000 | +81.0% | 397,404 | +118.4% | 0.00% | 0.0% |
Q3 2018 | $15,551,000 | -21.3% | 181,970 | +6.8% | 0.00% | -33.3% |
Q2 2018 | $19,749,000 | +60.2% | 170,398 | +11.9% | 0.01% | +50.0% |
Q1 2018 | $12,324,000 | +50.7% | 152,320 | +9.2% | 0.00% | +33.3% |
Q4 2017 | $8,180,000 | +27.0% | 139,428 | +1.3% | 0.00% | +50.0% |
Q3 2017 | $6,441,000 | +31.2% | 137,630 | +0.9% | 0.00% | 0.0% |
Q2 2017 | $4,908,000 | +32.2% | 136,420 | +13.1% | 0.00% | 0.0% |
Q1 2017 | $3,713,000 | -16.4% | 120,569 | -9.1% | 0.00% | 0.0% |
Q4 2016 | $4,441,000 | +32.3% | 132,584 | +5.1% | 0.00% | 0.0% |
Q3 2016 | $3,356,000 | +30.3% | 126,148 | +8.0% | 0.00% | +100.0% |
Q2 2016 | $2,575,000 | -32.7% | 116,813 | -10.4% | 0.00% | -50.0% |
Q1 2016 | $3,827,000 | +7.3% | 130,318 | +20.6% | 0.00% | 0.0% |
Q4 2015 | $3,568,000 | +3.3% | 108,070 | +13.0% | 0.00% | 0.0% |
Q3 2015 | $3,455,000 | -18.0% | 95,613 | +2.1% | 0.00% | 0.0% |
Q2 2015 | $4,213,000 | +61.3% | 93,653 | +9.8% | 0.00% | +100.0% |
Q1 2015 | $2,612,000 | -32.3% | 85,331 | +12.4% | 0.00% | -50.0% |
Q4 2014 | $3,860,000 | +75.1% | 75,923 | +36.3% | 0.00% | +100.0% |
Q3 2014 | $2,204,000 | +20.7% | 55,719 | +31.4% | 0.00% | 0.0% |
Q2 2014 | $1,826,000 | +52.5% | 42,399 | +41.6% | 0.00% | 0.0% |
Q1 2014 | $1,197,000 | +105.7% | 29,943 | +40.3% | 0.00% | – |
Q4 2013 | $582,000 | +18.1% | 21,347 | -0.8% | 0.00% | – |
Q3 2013 | $493,000 | +33.6% | 21,510 | +3.3% | 0.00% | – |
Q2 2013 | $369,000 | – | 20,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |